Activity of cabazitaxel in metastatic or inoperable locally advanced dedifferentiated liposarcoma: a phase 2 study of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG)
This phase 2 nonrandomized clinical trial examines the association of cabazitaxel treatment for patients with advanced dedifferentiated liposarcoma with progression-free survival.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
August 18, 2022
|
| In: |
JAMA oncology
Year: 2022, Jahrgang: 8, Heft: 10, Pages: 1420-1425 |
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2022.3218 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaoncol.2022.3218 Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389439/ |
| Verfasserangaben: | Roberta Sanfilippo, Richard L. Hayward, Jammbe Musoro, Charlotte Benson, Michael Gordon Leahy, Antonella Brunello, Jean-Yves Blay, Neeltje Steeghs, Ingrid M. E. Desar, Nasim Ali, Alice Hervieu, Khin Thway, Sandrine Marreaud, Saskia Litiere, and Bernd Kasper |
| Zusammenfassung: | This phase 2 nonrandomized clinical trial examines the association of cabazitaxel treatment for patients with advanced dedifferentiated liposarcoma with progression-free survival. |
|---|---|
| Beschreibung: | Gesehen am 22.08.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 2374-2445 |
| DOI: | 10.1001/jamaoncol.2022.3218 |